SCHEMBL4666815

SCHEMBL4666815

Cc1ccsc1-n1nc(-c2cccc(OC(C)C)c2)cc1N

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.42
NPC1 O15118 3/20 0.42
RAB9A P51151 3/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
NFKB1 P19838 1/20 0.42
NFKB2 Q00653 1/20 0.42
RELA Q04206 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
WDR5 P61964 1/20 0.42
MAP4K4 O95819 1/20 0.41
GABRA1 P14867 1/20 0.38
GABRG2 P18507 1/20 0.38
GABRB3 P28472 1/20 0.38
GABRA5 P31644 1/20 0.38
GABRA3 P34903 1/20 0.38
BACE1 P56817 1/20 0.37
KEAP1 Q14145 1/20 0.37
NFE2L2 Q16236 1/20 0.37
MAPT P10636 4/20 0.37
KLK3 P07288 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4666860 0.80 ALDH1A1 (0.43) ALDH1A1NPC1RAB9ASMN1; SMN2NFKB1
SCHEMBL4665241 0.75 DHODH (0.54) KEAP1NFE2L2MAPTTP53FABP3
SCHEMBL23809593 0.66 MAP4K4 (0.62) WDR5MAP4K4GABRA1GABRG2GABRB3
SCHEMBL4667871 0.65 NOTUM (0.44) ALDH1A1NPC1RAB9ASMN1; SMN2NFKB1
SCHEMBL4666632 0.64 MAP4K4 (0.50) SMN1; SMN2WDR5MAP4K4GABRA1GABRG2
SCHEMBL30469319 0.63 RXRA (0.57) ALDH1A1WDR5MAP4K4GABRA1GABRG2
SCHEMBL20557906 0.63 RXRA (0.57) ALDH1A1WDR5MAP4K4GABRA1GABRG2
SCHEMBL2409415 0.62 DHODH (0.53) WDR5MAP4K4GABRA1GABRG2GABRB3
SCHEMBL8252632 0.62 GABRA1 (0.54) ALDH1A1NPC1RAB9ASMN1; SMN2L3MBTL1
SCHEMBL13975280 0.62 KLK3 (0.55) ALDH1A1NPC1RAB9ASMN1; SMN2MAP4K4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1928455-A1 ANILINOPYRAZOLE DERIVATIVES USEFUL FOR THE TREATMENT OF DIABETES Bayer Healthcare, LLC (US) 2008-06-11 EP disclosed
WO-2007027842-A1 ANILINOPYRAZOLE DERIVATIVES USEFUL FOR THE TREATMENT OF DIABETES BAYER HEALTHCARE LLC (US) 2007-03-08 WO disclosed
WO-2007027842-A1 ANILINOPYRAZOLE DERIVATIVES USEFUL FOR THE TREATMENT OF DIABETES BAYER HEALTHCARE LLC (US) 2007-03-08 WO disclosed